Q4194 Novachor HCPCS: Reimbursement & Policy

HCPCS Level II code Q4194 identifies Novachor billed per square centimeter as an add-on item, reported in addition to a primary procedure. As an HCPCS Level II product code, it matters nationally for facilities and clinicians that provide advanced wound care or topical therapeutic agents and must bill adjunct supplies separately. Accurate use affects claim processing, reimbursement flows, and clinical supply tracking across settings that manage surgical wounds or specialized topical treatments.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose and billing context, payer coverage considerations, common modifiers used with similar add-on supply codes, and what to expect in claims reporting. The publication summarizes benchmarks and policy-relevant points for national payers, highlights clinical scenarios in which an add-on per-square-centimeter supply is applied, and notes where input data is not available.

This summary equips revenue cycle, coding, and clinical staff with the core facts needed to recognize when Q4194 should appear on a service line, understand its role as an add-on supply, and anticipate payer interactions and documentation needs.

Billing Code Overview

HCPCS Level II code Q4194 denotes Novachor, per square centimeter (add-on, list separately in addition to primary procedure). This code represents an add-on product billed in addition to a primary procedural code when Novachor is used and charged by surface area.

Service type: Product/adjunct topical or wound care agent billed as an add-on supply
Typical site of service: Settings where primary procedures involving wound care or topical therapeutic agents are provided, such as outpatient surgical centers, hospital outpatient departments, and wound care clinics

Data not available in the input.

Clinical Context

Novachor (decellularized human amniotic membrane product) is billed per square centimeter as an add-on material when used in the management of complex wounds or surgical soft-tissue defects. A typical patient is a 68-year-old with a nonhealing lower-extremity venous stasis ulcer refractory to conservative care who undergoes an outpatient wound-care procedure in a clinic or ambulatory surgery center. After debridement of devitalized tissue and assessment of wound bed viability, the clinician measures the defect and applies Q4194 Novachor to cover the wound surface, secured with an appropriate dressing. The product is billed in addition to the primary procedure code for debridement or wound repair. Typical sites of service include outpatient wound care clinics, ambulatory surgery centers, and inpatient hospital settings when applied during surgical procedures. Common clinical workflow steps: wound assessment and measurement, sharp/surgical debridement as indicated, hemostasis, application of Q4194 per measured square centimeters, dressing placement, documentation of product lot and area applied, and follow-up wound care visits for dressing changes and assessment of incorporation and healing.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier — default reporting	Use when no special circumstance modifier applies.

Taxonomy Code	Specialty	Notes
`177100000X`	Dermatology	Dermatologists commonly manage complex skin and soft-tissue wounds and apply biologic dressings.
`207Q00000X`	General Surgery	General surgeons perform debridement and soft-tissue reconstruction where Novachor may be used.
`208000000X`	Plastic Surgery	Plastic surgeons apply biologic grafts for soft-tissue coverage and wound reconstruction.
`246M00000X`	Vascular Surgery	Vascular surgeons treat chronic ischemic and venous ulcers and may use amniotic membrane products.
`163W00000X`	Podiatry	Podiatrists manage lower-extremity ulcers and apply advanced biologic wound therapies.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.909`	Non-pressure chronic ulcer of unspecified part of unspecified lower leg with unspecified severity	Chronic lower-extremity ulcers often receive biologic membrane products such as Novachor to promote healing.
`L98.491`	Noninfectious complication of skin graft	Used when grafting complications require additional biologic coverage or revision using products like `Q4194`.
`I83.013`	Varicose veins of bilateral lower extremities with ulcer of thigh	Venous stasis ulcers related to chronic venous disease are common indications for advanced wound therapies.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers frequently benefit from multilayer wound care and biologic adjuncts.
`T79.AXXA`	Traumatic amputation of other part of right lower leg, initial encounter	Complex soft-tissue defects after traumatic injury may receive amniotic membrane products as part of reconstruction.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Often billed when surgical debridement of the wound bed is performed immediately before application of `Q4194`.
`11043`	Debridement, muscle and fascia, first 20 sq cm or less	Billed when deeper debridement is required prior to biologic dressing placement.
`15271`	Placement of a biodegradable temporizing matrix or biologic dressing (e.g., acellular dermal matrix), for breast reconstruction — per cm2 (example analogous code)	Represents similar add-on biologic material placement and is used here as a conceptual comparator for reporting materials applied per area; `Q4194` is billed as an HCPCS add-on per cm2 in conjunction with a primary procedure.
`97597`	Debridement (eg, high pressure waterjet, sharp) including topical application(s), wound assessment and instruction(s) for ongoing care, first 20 sq cm or less	Outpatient wound debridement and care often precede or accompany application of `Q4194`.
`15236`	Full-thickness graft, free, first 20 sq cm or less; trunk, arms, legs (includes harvesting)	Performed when definitive coverage requires autograft in addition to or instead of biologic membrane products; may be part of the same surgical episode.

OpenPayer

Summary & Overview

HCPCS Q4194: Novachor, per Square Centimeter (Add-on)